The “problem person” isn’t necessarily sick — they might simply be the one expressing pain on behalf of everyone else.

Panelists discuss how comprehensive patient education materials and manufacturer resources help patients prepare for and ...

Moment of Clarity has released a new educational publication titled Transcranial Magnetic Stimulation in California, ...

Tamra Bedford, Cosmetic RN, a medical spa in San Ramon, California, continues to meet growing demand for advanced ...

SGLT2 inhibitors are a welcome addition to GN care, but the field is still grappling with the gap between molecular ...

Bermuda Cancer and Health Centre has announced a memorandum of understanding with the cancer charity and longstanding partner ...

Georgia ranks 46 in the nation for access to mental health care and has one of the nation’s highest rates of ...

We aim to provide transparency in how Elevance Health plans address variations in clinical practices to ensure safe, ...

While traditional induction therapy for newly diagnosed stage 2 myeloma often focuses on combinations of proteasome inhibitors, immunomodulatory drugs, and steroids, these newer immunotherapy classes ...

The U.S. Food and Drug Administration said on Friday it approved new labeling for Sarepta Therapeutics' gene therapy Elevidys ...

In the ever-evolving landscape of modern medicine, certain pharmaceutical breakthroughs capture widespread attention, not ...

Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...